The Life Sciences in New York State

Emisphere Technologies, Inc. Moves Into New Corporate Headquarters

OK, but I’m still calling them a Tarrytown-based company.

Emisphere Technologies, Inc. today announced it will move its corporate headquarters from Tarrytown, New York to Cedar Knolls, New Jersey

Emisphere Technologies, Inc. Moves Into New Corporate Headquarters.

OSI Pharmaceuticals Rises on 3Q Results: Financial News - Yahoo! Finance

NEW YORK (AP) -- Shares of OSI Pharmaceuticals Inc. rose Friday after it raised its 2007 guidance on better-than-expected third-quarter results, and analysts predicted renewed growth for the biotechnology company's flagship drug.

OSI Pharmaceuticals Rises on 3Q Results: Financial News - Yahoo! Finance.

Inhaled insulin: make or break?

Fair question. I don’t blame Lilly for taking the stance that they are taking. In fact, I don’t think Lilly has much of a choice at this point. It’s interesting that Novo is already lowering expectations with their product by stating that inhaled insulin may not be a blockbuster product.

 

Eli Lilly is remaining optimistic about its yet-to-be-approved inhaled insulin despite the dramatic downfall of Pfizer's Exubera. But is Exubera's fall from grace an indication of things to come for inhaled diabetes treatments?
Eli Lilly is remaining optimistic about its yet-to-be-approved inhaled insulin despite the dramatic downfall of Pfizer's Exubera. But is Exubera's fall from grace an indication of things to come for inhaled diabetes treatments?

 

Inhaled insulin: make or break?.